- Home
- ENOV vs POWL Comparison
ENOV vs POWL Comparison
Compare ENOV & POWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- POWL
- Stock Information
- Founded
- ENOV 1995
- POWL 1947
- Country
- ENOV United States
- POWL United States
- Employees
- ENOV N/A
- POWL N/A
- Industry
- ENOV Fluid Controls
- POWL Electrical Products
- Sector
- ENOV Industrials
- POWL Energy
- Exchange
- ENOV Nasdaq
- POWL Nasdaq
- Market Cap
- ENOV 2.1B
- POWL N/A
- IPO Year
- ENOV 2008
- POWL N/A
- Fundamental
- Price
- ENOV $36.95
- POWL $181.30
- Analyst Decision
- ENOV Buy
- POWL Strong Buy
- Analyst Count
- ENOV 4
- POWL 1
- Target Price
- ENOV $58.50
- POWL $312.00
- AVG Volume (30 Days)
- ENOV 849.1K
- POWL 379.5K
- Earning Date
- ENOV 05-01-2025
- POWL 04-29-2025
- Dividend Yield
- ENOV N/A
- POWL 0.59%
- EPS Growth
- ENOV N/A
- POWL 106.54
- EPS
- ENOV N/A
- POWL 13.17
- Revenue
- ENOV $2,107,623,000.00
- POWL $1,059,770,000.00
- Revenue This Year
- ENOV $7.09
- POWL $13.99
- Revenue Next Year
- ENOV $6.38
- POWL $3.99
- P/E Ratio
- ENOV N/A
- POWL $13.77
- Revenue Growth
- ENOV 23.45
- POWL 38.27
- 52 Week Low
- ENOV $34.44
- POWL $122.00
- 52 Week High
- ENOV $62.79
- POWL $364.98
- Technical
- Relative Strength Index (RSI)
- ENOV 38.61
- POWL 48.85
- Support Level
- ENOV $36.43
- POWL $161.23
- Resistance Level
- ENOV $38.56
- POWL $201.00
- Average True Range (ATR)
- ENOV 1.44
- POWL 9.49
- MACD
- ENOV 0.08
- POWL 1.60
- Stochastic Oscillator
- ENOV 40.10
- POWL 50.47
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.